Clinical and biochemical predictors of efficacy of and side effects from azathioprine in patients with inflammatory bowel disease (IBD)

被引：1
|
作者：
McGovern, DP
Hussaini, H
Worthington, J
Reynolds, NJ
Shobowale-Bakre, EM
Duley, JA
Dalton, HR
机构：
[1] Royal Cornwall Hosp, Gastrointestinal Unit, Truro, Cornwall, England
[2] Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[3] Acad & St Thomas Hosp, Purine Res Lab, London, England
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)85294-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4206
引用
收藏
页码：A788 / A788
页数：1
相关论文
共 50 条
  • [11] Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease
    Lamers, CBHW
    Griffioen, G
    van Hogezand, RA
    Veenendaal, RA
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 : 111 - 115
  • [12] Azathioprine treatment in inflammatory bowel disease patients: type and time of onset of side effects
    Avallone, E. V.
    Pica, R.
    Cassieri, C.
    Zippi, M.
    Paoluzi, P.
    Vernia, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (02) : 165 - 170
  • [13] Bone metabolism (BM) in patients with inflammatory bowel disease (IBD) in clinical and biochemical remission.
    Menge, F
    Karmatschek, M
    Caspary, WF
    Goethe, JW
    Stein, JM
    GASTROENTEROLOGY, 1999, 116 (04) : A774 - A774
  • [14] Incidence of benign infections in inflammatory bowel disease (IBD) patients treated with azathioprine (AZA)
    Seksik, Philippe
    Cosnes, Jacques
    Nion-Larmuier, Isabelle
    Gendre, Jean-Pierre
    Beaugene, Laurent
    GASTROENTEROLOGY, 2006, 130 (04) : A72 - A72
  • [15] Long term efficacy of azathioprine monotherapy in patients with Inflammatory Bowel Disease
    Theodoraki, E.
    Papatzelou, I.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1444 - I1444
  • [16] Finding Predictors of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel Disease
    Freitas, Marta
    Lima Capela, Tiago
    Macedo Silva, Vitor
    Arieira, Catia
    Curdia Goncalves, Tiago
    Dias de Castro, Francisca
    Moreira, Maria Joao
    Firmino-Machado, Joao
    Cotter, Jose
    PANCREAS, 2022, 51 (03) : 288 - 294
  • [17] Finding predictors of azathioprine-induced pancreatitis in patients with inflammatory bowel disease
    Freitas, M.
    Capela, T.
    Macedo Silva, V.
    Arieira, C.
    Curdia Goncalves, T.
    Dias de Castro, E.
    Moreira, M. J.
    Cotter, J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S543 - S543
  • [18] Predictors of short and long term response to azathioprine in patients with inflammatory bowel disease
    Mardini, H
    Selby, L
    Arsenescu, R
    Winter, T
    de Villiers, WJ
    GASTROENTEROLOGY, 2005, 128 (04) : A582 - A582
  • [19] Gastrointestinal side effects of azathioprine in patients with inflammatory bowel disease are not related to thiopurine methyltransferase polymorphism.
    Kaskas, BA
    SchSffeler, E
    Lang, T
    Zanger, U
    Marx, C
    Fischer, C
    Eichelbaum, M
    Gregor, M
    Schwab, M
    GASTROENTEROLOGY, 2000, 118 (04) : A787 - A787
  • [20] Determination of thiopurine methyltransferase (TPMT) activity in patients with inflammatory bowel disease (IBD) treated with azathioprine
    Sans, M
    Bufadel, ME
    Cara, C
    Penalva, M
    Pique, JM
    Panés, J
    GASTROENTEROLOGY, 2002, 122 (04) : A221 - A222
12345